ProstaLund AB Total Liabilities

Latest as of June 2025: Skr11.30 Million SEK ≈ $1.22 Million USD

ProstaLund AB total liabilities. Based on the latest financial reports, ProstaLund AB (PLUN) has total liabilities worth Skr11.30 Million SEK (≈ $1.22 Million USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. See operational self-sufficiency of ProstaLund AB to measure how many days the company can operate on defensive assets alone.

Total Liabilities of ProstaLund AB (2012–2024)

Total liabilities of ProstaLund AB from 2012 to 2024. This chart illustrates how ProstaLund AB's total liabilities have evolved over time, based on quarterly financial data.

ProstaLund AB Competitors by Total Liabilities

The table below lists competitors of ProstaLund AB ranked by their total liabilities.

Company Country Total Liabilities
RightBridge Ventures Group AB
ST:RIGHTB
Sweden Skr15.38 Million
ARCTIC BLUE BEVERAGES AB
F:U5L
Germany €23.26 Million
Kollect on Demand Holding Ab
ST:KOLL
Sweden Skr10.37 Million
Strikewell Energy Corp
V:SKK
Canada CA$28.37 Million
CERo Therapeutics Holdings, Inc. Common Stock
NASDAQ:CERO
USA $32.41 Million
Glen Eagle Resources Inc
V:GER
Canada CA$4.08 Million
EUROPA MET. LTD POST CONS
F:WRE1
Germany €67.11K
Onward Opportunities Ltd
LSE:ONWD
UK GBX300.00K

Liability Composition Analysis (2012–2024)

This chart breaks down ProstaLund AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see ProstaLund AB (PLUN) total assets.

Liquidity & Leverage Metrics

ProstaLund AB Total Liabilities Ratios Explained

ProstaLund AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 2.00 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.25 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.20 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how ProstaLund AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for ProstaLund AB (2012–2024)

The table below shows the annual total liabilities of ProstaLund AB from 2012 to 2024.

Year Total Liabilities Change
2024-12-31 Skr6.46 Million
≈ $694.88K
-36.80%
2023-12-31 Skr10.22 Million
≈ $1.10 Million
+9.18%
2022-12-31 Skr9.36 Million
≈ $1.01 Million
+16.61%
2021-12-31 Skr8.02 Million
≈ $863.51K
+46.29%
2020-12-31 Skr5.49 Million
≈ $590.27K
+31.95%
2019-12-31 Skr4.16 Million
≈ $447.36K
-35.50%
2018-12-31 Skr6.45 Million
≈ $693.58K
+55.34%
2017-12-31 Skr4.15 Million
≈ $446.50K
-6.15%
2016-12-31 Skr4.42 Million
≈ $475.77K
+13.10%
2015-12-31 Skr3.91 Million
≈ $420.67K
-1.54%
2014-12-31 Skr3.97 Million
≈ $427.24K
-9.30%
2013-12-31 Skr4.38 Million
≈ $471.04K
+96.90%
2012-12-31 Skr2.22 Million
≈ $239.23K
--

About ProstaLund AB

ST:PLUN Sweden Medical Care Facilities
Market Cap
$716.78K
Skr6.66 Million SEK
Market Cap Rank
#30870 Global
#717 in Sweden
Share Price
Skr0.21
Change (1 day)
+0.00%
52-Week Range
Skr0.21 - Skr0.21
All Time High
Skr15.54
About

ProstaLund AB (publ), a medical technology company, develops, manufactures, and sells urological devices and treatments in Sweden and internationally. It offers CoreTherm, a heat treatment for benign prostate enlargement; CoreFlow, a temporary prostate stent; Oruflow, a urine flow meter; and Schelin Catheter, a medical device intended for intraprostatic and periprostatic injection of legally mark… Read more